PRE on Nasdaq

Prenetics Global Ltd

Pharmaceutical preparations company in the Cayman Islands. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with CAPRICOR THERAPEUTICS, INC., NextCure, Inc. or NewAmsterdam Pharma Co N.V., or pick any stock.

  • TickerPRE on Nasdaq1
  • IndustryPharmaceutical Preparations1
  • HeadquartersQuarry Bay, Hong Kong1
  • Incorporated inCayman Islands2
  • Business address7/F, K11 Atelier, 728 King'S Road, Quarry Bay, K3 0000002
  • Filer categoryNon-accelerated filer, Emerging growth company2

See how the biggest companies compare on our leaderboards

IM8 is the flagship brand of Prenetics. Prenetics was founded in 2014 in Hong Kong by Danny Yeung and has evolved—through a series of deliberate strategic pivots—from a genomic testing company into a consumer health and longevity platform. IM8 was co-founded with David Beckham and launched in December 2024. Its performance in FY2025 accelerated a strategic conclusion: Prenetics would become a consumer health company, and IM8 would be its engine.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

40.6%Gross margin4
-238.7%Operating margin4
-297.9%Net margin4
65.2%Revenue growth, 20235
-30.8%Return on equity4
-$14.1MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue52¢$12.9M
  • Research and development47¢$11.7M
  • Income tax1¢$269.0K

Out of $21.7M in revenue.54 The company lost money this year.

Financial statements

Revenue65$21.7M in 2023−67% since 2020
0$20.0M$40.0M$60.0M$80.0M2020: $65.2M$65.2M20202021: $12.5M$12.5M2021−81%2022: $13.2M$13.2M2022+5%2023: $21.7M$21.7M2023+65%
Gross profit654$8.8M in 2023−66% since 2020
0$10.0M$20.0M$30.0M2020: $26.3M$26.3M20202021: $3.6M$3.6M2021−86%2022: $3.6M$3.6M2022+0%2023: $8.8M$8.8M2023+144%
Operating income654-$51.9M in 2023+5116% since 2020
-$80.0M-$60.0M-$40.0M-$20.0M02020: -$995.1K-$995.1K20202021: -$56.7M-$56.7M2021+5594%2022: -$66.0M-$66.0M2022+17%2023: -$51.9M-$51.9M2023−21%
Net income654-$64.8M in 2023+3198% since 2020
-$200.0M-$150.0M-$100.0M-$50.0M02020: -$2.0M-$2.0M20202021: -$174.0M-$174.0M2021+8761%2022: -$190.5M-$190.5M2022+9%2023: -$64.8M-$64.8M2023−66%
Fiscal year20192020202120222023
Revenue$65.2M6$12.5M5$13.2M5$21.7M5
Cost of revenue$8.9M5$9.5M4$12.9M4
Gross profit$26.3M6$3.6M5$3.6M4$8.8M4
Research and development$6.4M5$6.0M4$11.7M4
Operating income-$995.1K6-$56.7M5-$66.0M4-$51.9M4
Interest$5.2M6$4.2M6
Income before tax-$216.6M5-$225.8M4-$56.7M4
Income tax$2.6M5-$245.0K4-$269.0K4
Net income-$2.0M6-$174.0M5-$190.5M4-$64.8M4
Earnings per share-$0.156-$178.815-$37.574-$5.584
Earnings per share (diluted)-$0.156-$178.815-$37.574-$5.584
Shares (weighted, basic)973.1K shares55.1M shares411.2M shares4
Shares (weighted, diluted)5.1M shares411.2M shares4

Compare Prenetics Global Ltd with another company

Leadership

Who has led Prenetics Global Ltd, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Danny Sheng Wu Yeung2026–now

Chief financial officer

  1. Hoi Chun Lo2026
  2. Brian J. Rosin2026–now
Board members and other officers (7)

Timeline

  1. Mar 30, 2026New chief executive Danny Sheng Wu Yeung becomes CEO7

Filings

244 filings to the SEC since October 2021: 9 annual reports, 23 insider forms, 18 large holders, 194 other. The latest 20:

  1. Oct 13, 20266-K EDGAR
  2. Oct 6, 20264 EDGAR
  3. Oct 2, 20264 EDGAR
  4. Sep 22, 2026F-1/A EDGAR
  5. Sep 8, 2026F-1/A EDGAR
  6. Sep 4, 202620-F/A EDGAR
  7. Sep 4, 20264 EDGAR
  8. Sep 4, 20264 EDGAR
  9. Aug 26, 20266-K EDGAR
  10. Aug 26, 20264 EDGAR
  11. Aug 26, 20263 EDGAR
  12. Aug 24, 20264 EDGAR
  13. Aug 24, 20264 EDGAR
  14. Aug 21, 2026S-8 EDGAR
  15. Aug 20, 20266-K EDGAR
  16. Aug 18, 20266-K EDGAR
  17. Aug 17, 20266-K EDGAR
  18. Aug 12, 20263 EDGAR
  19. Aug 7, 2026F-1/A EDGAR
  20. Aug 7, 20266-K EDGAR

The 244 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

4 open-market trades by officers, directors and large owners since October 2021: 4 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 25, 2026Rosin Brian JCFO of IM8 (US) LLCBuy5,100$22.80$116.3KForm 4
Aug 24, 2026Rosin Brian JCFO of IM8 (US) LLCBuy18,000$21.19$381.4KForm 4
Aug 24, 2026Yeung Danny Sheng WuChief Executive OfficerBuy17,181$21.23$364.7KForm 4
Aug 20, 2026Yeung Danny Sheng WuChief Executive OfficerBuy7,500$18.31$137.3KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24